AU2281595A - Method of combating mammalian neoplasia, and lytic peptides therefor - Google Patents

Method of combating mammalian neoplasia, and lytic peptides therefor

Info

Publication number
AU2281595A
AU2281595A AU22815/95A AU2281595A AU2281595A AU 2281595 A AU2281595 A AU 2281595A AU 22815/95 A AU22815/95 A AU 22815/95A AU 2281595 A AU2281595 A AU 2281595A AU 2281595 A AU2281595 A AU 2281595A
Authority
AU
Australia
Prior art keywords
combating
therefor
lytic peptides
mammalian neoplasia
neoplasia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22815/95A
Other languages
English (en)
Inventor
Jesse M. Jaynes
Gordon R Julian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Demeter Biotechnologies Ltd
Original Assignee
Demeter Biotechnologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Demeter Biotechnologies Ltd filed Critical Demeter Biotechnologies Ltd
Publication of AU2281595A publication Critical patent/AU2281595A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43572—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Insects & Arthropods (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU22815/95A 1994-04-08 1995-04-06 Method of combating mammalian neoplasia, and lytic peptides therefor Abandoned AU2281595A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22547694A 1994-04-08 1994-04-08
US225476 1994-04-08
PCT/US1995/004335 WO1995027497A1 (fr) 1994-04-08 1995-04-06 Methode permettant de combattre la neoplasie mammalienne et peptides lytiques utilises dans ladite methode

Publications (1)

Publication Number Publication Date
AU2281595A true AU2281595A (en) 1995-10-30

Family

ID=22845029

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22815/95A Abandoned AU2281595A (en) 1994-04-08 1995-04-06 Method of combating mammalian neoplasia, and lytic peptides therefor

Country Status (3)

Country Link
AU (1) AU2281595A (fr)
IL (1) IL113244A0 (fr)
WO (1) WO1995027497A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527775A (en) * 1994-10-13 1996-06-18 Enzon, Inc. Reduction of mammalian neoplasms with phospholipase A2 activating substances
US6042848A (en) * 1996-08-15 2000-03-28 The Board Of Trustees Of Southern Illinois University Enhancement of antimicrobial peptide activity by metal ions
US8283315B2 (en) 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
GB0605685D0 (en) * 2006-03-21 2006-05-03 Lytix Biopharma As Inhibition of tumour growth
KR100438416B1 (ko) * 2001-09-19 2004-07-02 학교법인조선대학교 Ｃａ－ｍａ 펩타이드의 아미노산 중 하나 또는 그 이상을치환하여 ＋ 전극과 소수성 영역이 증가된 신규한펩타이드 및 그를 포함하는 약학적 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810777A (en) * 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds
ATE189231T1 (de) * 1989-04-10 2000-02-15 Helix Biomedix Inc Lytische peptide, verwendung als wachstumsfördernde mittel und für infektionen und krebs

Also Published As

Publication number Publication date
WO1995027497A1 (fr) 1995-10-19
IL113244A0 (en) 1995-07-31

Similar Documents

Publication Publication Date Title
AU7700598A (en) Tissue dissociating system and method
AU4978097A (en) Catalyst and method of preparation
AU7250098A (en) Anastomosis system and method of use
AU5422696A (en) Nox catalyst and method of using the same
AU1108695A (en) Aza-4-iminoquinolines, methods of preparing them and their use
AU4597297A (en) Trans-sodium crocetinate, methods of making and methods of use thereof
AU1771195A (en) Method of administering azithromycin
PL330903A1 (en) Aqueous preparations of peptides
AU7177798A (en) Cosmetic preparations
AU7177698A (en) Cosmetic preparations
AU2446495A (en) Naphthalene derivatives, method of preparation and use
AU2749395A (en) Medical use of bromelain
AU2627595A (en) Submarine weapon-handling and discharge system
EP0780470A3 (fr) Beta-fructofuranosidase, son procédé de préparation et ses utilisations
AU3241895A (en) Apoptosis related protein bcl-y, and methods of use thereof
AU4418096A (en) Diagnosis of pancreatitis
AUPN861496A0 (en) Lytic peptides
AU1841195A (en) 1-beta -methyl-carbapenem, compositions containing same and methods of use
AU3893495A (en) Solution sterilization system and method of operation
AU2281595A (en) Method of combating mammalian neoplasia, and lytic peptides therefor
AU1314995A (en) Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
AU5550296A (en) Conotoxin peptides
AU8578598A (en) Anti-inflammatory factor, method of isolation, and use
AUPO366496A0 (en) Collagen preparations
AU5219798A (en) Gpi-ceruloplasmin, analogs thereof, and methods of use